BL-3

The name **BL-3** is a non-specific identifier used in various academic and pharmaceutical research contexts to denote the third compound in a series. In the provided context, it refers to several distinct substances: 1. **A PTP1B Inhibitor:** A racemic butenolide derivative synthesized as an analogue of butyrolactone I (a metabolite from *Aspergillus terreus*). It is investigated for the treatment of **type 2 diabetes mellitus** due to its ability to inhibit protein tyrosine phosphatase 1B (PTP1B), thereby improving insulin resistance. 2. **A Ruthenium Complex Ligand:** Specifically **1,3-bis(4-pyridyl)propane**, which serves as a bridging ligand in dinuclear η6-arene Ru(II) complexes. These complexes are studied for their DNA-binding properties and cytotoxic activity against cancer cell lines such as A2780 and MCF-7. 3. **A Chalcone Derivative:** A specific chalcone identified through computational docking as a potential inhibitor of the **Dengue virus NS5 methyltransferase** domain, showing promise as an anti-DENV agent. 4. **A Scorpion Peptide:** An insecticidal 65-residue peptide isolated from the venom of the North African scorpion *Buthacus leptochelys*, which likely acts on sodium channels. Additionally, **BL-3** is widely recognized in veterinary research as a **bovine B-lymphocyte cell line** used to study pathogens like Bovine Viral Diarrhea Virus (BVDV) and *Mannheimia haemolytica*.

Other names

1,3-bis(4-pyridyl)propaneButyrolactone I analogue BL-3Chalcone BL-3